Supplementary Methods
Immunohistochemistry. Testes were collected from each of the two wild-type males and tm homozygous mutant males at three months after birth. They were fixed using 10% neutral buffered formalin, dehydrated, embedded in paraffin, and then cut to 5 µm thickness.
Immunostaining was conducted using a polyclonal rabbit Spata22 antibody. The primary antibody was used at 1:100 dilution and incubated at 4°C for 24 h. Staining was developed using the Vectastain ABC kit (Vector) in accordance with the manufacturer's standard protocol. Supplementary Table 1 . The number of Rad51, Spata22, and Mlh1 foci during each substage of prophase I.
Early leptotene
10.9 ± 5.4 ( n = 7 ) ( n = 10 ) Leptotene 72.7 ± 25.6 ( n = 7 ) 45.0 ± 19.6 ( n = 5 )
Early zygotene 160.8 ± 50.6 ( n = 16 ) 211.1 ± 59.9 ( n = 11 )
Mid-zygotene 161.9 ± 28.6 ( n = 8 ) 305.9 ± 15.3 ( n = 12 )
Late zygotene 125.7 ± 21.9 ( n = 7 ) 238.2 ± 31.1 ( n = 10 )
Early pachytene 31.3 ± 10.1 ( n = 6 ) 202.7 ± 21.1 ( n = 6 ) 11.4 ± 6.5 ( n = 13 )
Mid-pachytene 24.4 ± 11.4 ( n = 8 ) 139.1 ± 18.3 ( n = 8 ) 20.9 ± 2.7 ( n = 9 )
Late pachytene ( n = 6 ) 20.1 ± 12.3 ( n = 7 ) 15.8 ± 3.0 ( n = 12 ) Diplotene ( n = 5 ) 10.7 ± 6.7 ( n = 3 ) 385.2 ± 29.9 379.8 ± 31.9 387.4 ± 30.7
Percentage (mean ± s.d.)
Spata22 Rpa 22.6 ± 5.7 78.6 ± 15.0 72.9 ± 3.7 54.0 ± 18.6 40.6 ± 11.0 55.2 ± 12.9 17.1 ± 12.5 60.3 ± 8.3
98.0 ± 1.4 3.5 ± 1.5 98.7 ± 0.8 96.4 ± 1.5 191.6 ± 36.4 189.2 ± 36.5 195.8 ± 34.8
1.2 ± 0.7 95.2 ± 1.7
1.4 ± 1.2 96.7 ± 2.6 1.9 ± 1.4 98.6 ± 1.3
Supplementary 30.8 ± 7.8 2.6 ± 2.2 26.6 ± 3.5 50.9 ± 5.1 4.8 ± 3.6 44.3 ± 4.9 8.4 ± 6.3 9.8 ± 7.3
125.4 ± 23.4 14.8 ± 1.5 17.6 ± 2.4 85.8 ± 3.9 11.9 ± 2.8 2.3 ± 1.7
Supplementary Table 5 . The number of Rpa and Rad51 foci in wild-type and tm/tm spermatocytes.
Stage
Early leptotene (WT) Early leptotene-like (tm/tm ) (n = 6) (n = 5) 13.6 ± 7.1 (n = 8) 14.9 ± 7.8 (n = 9)
Leptotene (WT) Leptotene-like (tm/tm ) 35.7 ± 22.2 (n = 7) 40.5 ± 19.1 (n = 12) 72.4 ± 19.5 (n = 13) 58.5 ± 11.8* (n = 10)
Early zygotene (WT) Early zygotene-like (tm/tm ) 171.7 ± 52.7 (n = 27) 156.4 ± 68.7 (n = 23) 158.0 ± 50.3 (n = 29) 60.9 ± 23.1** (n = 35)
Mid-zygotene (WT) Mid-late zygotene-like (tm/tm ) 293.2 ± 36.1 (n = 9) 306.5 ± 22.8 (n = 22) 161.9 ± 28.6 (n = 8) 9.9 ± 8.8** (n = 28)
Late zygotene (WT) Mid-late zygotene-like (tm/tm ) 221.6 ± 21.0 (n = 9) 306.5 ± 22.8** (n = 22) 132.8 ± 26.3 (n = 12) 9.9 ± 8.8** (n = 28) ND ND s.d., standard deviation; n, number of nuclei used for examination; ND, not detected; ** and *, statistically significant with the wild type at 1 and 5% probability by the Mann-Whitney U-test (two-tailed).
Number of foci/nucleus (mean ± s. 
S u p p l e me n t a r y F i g u r e 1 . S p a t a 2 2 i s e x p r e s s e d i n t h e n u c l e i o f r a t p r i ma r y s p e r ma t o c y t e s .
( a , b ) I mmu n o h i s t o c h e mi s t r y o f t h e a d u l t wi l d -t y p e t e s t i s wi t h a n t i -S p a t a 2 2 a n t i b o d y . S p a t a 2 2 e x p r e s s i o n wa s r e s t r i c t e d t o t h e s p e r ma t o c y t e s ( a , d a r k b r o wn s t a i n i n g ) . Hi g h e r ma g n i f i c a t i o n s h o ws d i s c r e t e s u b n u c l e a r s t a i n i n g i n s p e r ma t o c y t e s ( b ) . Nu c l e i we r e c o u n t e r s t a i n e d wi t h me t h y l g r e e n .
S u p p l e me n t a r y F i g u r e 2 . Co l o c a l i s a t i o n o f S p a t a 2 2 wi t h Rp a , Ra d 5 1 , a n d Ml h 1 i n s p e r ma t o c y t e n u c l e i . ( a -f ) I mmu n o l o c a l i s a t i o n o f S p a t a 2 2 ( g r e e n ) a n d Rp a ( r e d ) i n t h e s p e r ma t o c y t e n u c l e i a t t h e l e p t ot e n e -l i k e ( a -c ) a n d e a r l y -mi d -p a c h y t e n e -l i k e ( d -f ) s t a g e s . S p a t a 2 2 a n d Rp a f o c i o v e r l a p p e d e x t e n s i v e l y wi t h e a c h o t h e r i n b o t h s u b s t a g e s . Co l o c a l i s a t i o n o f t h e t wo p r o t e i n s wa s f o u n d i n t h e t e r mi n a l s e g me n t s o f s e x c h r o mo s o me s i n t h e e a r l y -mi d -p a c h y t e n e -l i k e n u c l e u s ( d -f , a r r o wh e a d s ) . ( g -l ) I mmu n o l o c a l i s a t i o n o f S p a t a 2 2 ( g r e e n ) a n d Ra d 5 1 ( r e d ) i n t h e n u c l e i a t t h e z y g o t e n e -l i k e ( g -i ) a n d e a r l y -mi d -p a c h y t e n e -l i k e
( j -l ) s t a g e s s h o ws t h a t a s u b s e t o f t h e S p a t a 2 2 f o c i o v e r l a p p e d wi t h Ra d 5 1 f o c i . Co mp l e t e o v e r l a p , p a r t i a l o v e r l a p , a n d n o n -o v e r l a p b e t we e n t h e t wo p r o t e i n s ' f o c i a r e i n d i c a t e d b y l a r g e a r r o wh e a d s , s ma l l a r r o wh e a d s , a n d a r r o ws , r e s p e c t i v e l y ( g -l ) . Mi x e d f o c i we r e p r e s e n t i n t h e s e x c h r o mo s o me s ( X Y ) i n t h e e a r l ymi d -p a c h y t e n e -l i k e n u c l e u s ( j -l , a s t e r i s k s ) . ( m-o ) I mmu n o l o c a l i s a t i o n o f S p a t a 2 2 ( g r e e n ) a n d Ml h 1 ( r e d ) i n t h e l a t e p a c h y t e n e -l i k e n u c l e u s . T h e n u c l e u s wa s c o u n t e r s t a i n e d wi t h 4 ' , 6 -d i a mi d i n o -2 -p h e n y l i n d o l e ( DA P I ) ( b l u e ) . Ml h 1 f o c i a n d S p a t a 2 2 f o c i o v e r l a p p e d wi t h e a c h o t h e r a t t wo s i t e s i n t h e n u c l e u s ( a r r o ws ) .
S c a l e b a r s i n a l l p a n e l s , 1 0 μ m. 
S u p p l e me n t a r y F i g u r e 4 . Me i o t i c p r o g r e s s i o n i n t h e t m h o mo z y g o u s r a t .
( ( a -k ) I mmu n o l o c a l i s a t i o n o f S y c p 3 ( g r e e n ) i n t h e s p r e a d n u c l e i o f t h e wi l d -t y p e ( u p p e r p a n e l s ) a n d t m h o mo z y g o u s ( l o we r p a n e l s ) s p e r ma t o c y t e s a t t h e l e p t o t e n e ( a ) , e a r l y z y g o t e n e ( b , c ) , mi d -z y g o t e n e ( d ) , l a t e z y g o t e n e ( e ) , p a c h y t e n e ( f ) , l e p t o t e n e -l i k e ( g ) , e a r l y z y g o t e n e -l i k e ( h , i ) , a n d mi d -l a t e z y g o t e n e -l i k e ( j , k ) s t a g e s . Ch r o mo s o me mo r p h o l o g i e s we r e n o r ma l i n t h e mu t a n t n u c l e i d u r i n g t h e l e p t o t e n e -a n d e a r l y z y g o t e n e -l i k e s t a g e s ( a -c , g -i ) . Re p r e s e n t a t i v e s o f mu t a n t n u c l e i a t t h e mi d -l a t e z y g o t e n e -l i k e s t a g e t h a t c o n t a i n c h r o mo s o me s t h a t e x h i b i t n o nh o mo l o g o u s p a i r i n g ( a r r o ws ) ( j , k ) . Re p r e s e n t a t i v e o f mu t a n t n u c l e u s a t t h e mi d -l a t e z y g o t e n e
l i k e s t a g e t h a t c o n t a i n s c h r o mo s o me s t h a t e x h i b i t h o mo l o g o u s p a i r i n g ( a r r o wh e a d ) ( k ) . T h e r e p r e s e n t a t i v e o f wi l d -t y p e n u c l e u s a t p a c h y t e n e t h a t s h o ws c o mp l e t i o n o f h o mo l o g o u s c h r o -
mo s o me p a i r i n g ( f ) . " X Y " i n d i c a t e s t h e s e x c h r o mo s o me s . S c a l e b a r s i n a l l p a n e l s , 1 0 μ m.
S u p p l e me n t a r y F i g u r e 5 . Di s t r i b u t i o n o f γ -H2 AF X i n t h e wi l d -t y p e l e p t o t e n e a n d t m
h o mo z y g o u s l e p t o t e n e -l i k e s p e r ma t o c y t e s . I mmu n o l o c a l i s a t i o n o f γ -H2 A F X ( r e d ) a n d S y c p 3 ( g r e e n ) i n t h e wi l d -t y p e ( l e f t ) a n d t m h o mo z y g o u s ( r i g h t ) s p e r ma t o c y t e n u c l e i .
γ -H2 A F X wa s d i s t r i b u t e d t h r o u g h o u t t h e c h r o ma t i n i n b o t h t h e wi l d -t y p
e l e p t o t e n e a n d mu t a n t l e p t o t e n e -l i k e s p e r ma t o c y t e s . S c a l e b a r s i n a l l p a n e l s , 1 0 μ m.
S u p p l e me n t a r y F i g u r e 6 . E f f e c t s o f S p a t a 2 2 d e l e t i o n o n l o c a l i s a t i o n s o f Rp a a n d Ra d 5 1 .
( ( a -f ) I mmu n o l o c a l i s a t i o n o f Rp a ( g r e e n ) a n d S y c p 3 ( r e d ) i n t h e wi l d -t y p e ( l e f t p a n e l s ) a n d t m h o mo z y g o u s ( r i g h t p a n e l s ) s p e r ma t o c y t e n u c l e i a t t h e e a r l y z y g o t e n e ( a , b ) , l a t e z y g o t e n e ( c ) , e a r l y z y g o t e n e -l i k e ( d , e ) , a n d mi d -l a t e z y g o t e n e -l i k e ( f ) s t a g e s . Rp a f o c i we r e a b u n d a n t i n t h e mu t a n t mi d -l a t e -z y g o t e n e -l i k e n u c l e u s ( s e e F i g . 2 i ) . ( g -l ) I mmu n o l o c a l i s a t i o n o f Ra d 5 1 ( g r e e n ) a n d S y c p 3 ( r e d ) i n t h e wi l d -t y p e ( l e f t p a n e l s ) a n d t m h o mo z y g o u s ( r i g h t p a n e l s ) s p e r ma t o c y t e n u c l e i a t t h e e a r l y z y g o t e n e ( g , h ) , l a t e z y g o t e n e ( i ) , e a r l y z y g o t e n e -l i k e ( j , k ) , a n d mi d -l a t e z y g o t e n e -l i k e ( l ) s t a g e s . F e we r Ra d 5 1 f o c i we r e o b s e r v e d i n t h e mu t a n t n u c l e i t h a n i n t h e wi l dt y p e c o n t r o l s ( s e e F i g . 2 j ) . S c a l e b a r s i n a l l p a n e l s , 1 0 μ m.
